PlainRecalls
FDA Drug Moderate Class II Terminated

PHENYLephrine HCl 400 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 40 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0811-12, Bar Code 70004081112.

Reported: April 3, 2024 Initiated: November 9, 2023 #D-0418-2024

Product Description

PHENYLephrine HCl 400 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 40 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0811-12, Bar Code 70004081112.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
SCA Pharmaceuticals, LLC
Units Affected
10,017 syringes, expanded 2579 syringes
Distribution
Nationwide in the USA
Location
Windsor, CT

Frequently Asked Questions

What product was recalled?
PHENYLephrine HCl 400 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 40 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0811-12, Bar Code 70004081112.. Recalled by SCA Pharmaceuticals, LLC. Units affected: 10,017 syringes, expanded 2579 syringes.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on April 3, 2024. Severity: Moderate. Recall number: D-0418-2024.